ITGB2-COPS3-SOX2轴和SOX2液-液相分离:控制骨肉瘤干的双重机制
Lei Guo1, Zhiqing Zhao1, Wei Wang1
1Department of Orthopedics, Peking University First Hospital, Peking University, Beijing, China.
Advanced science (Weinheim, Baden-Wurttemberg, Germany)
|March 13, 2026
概括
这项研究揭示了COPS3如何通过稳定SOX2,这是癌症进展的关键因素,从而驱动骨髓瘤茎的作用. 一种新的COPS3抑制剂,Z-5891,在减少瘤生长和干度方面显示出有前途.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 遗传学 是一个遗传学.
背景情况:
- 骨髓瘤是一种青少年的恶性骨瘤.
- 癌症干细胞 (CSCs) 在骨髓瘤中驱动化疗抵抗和转移.
- 17p11.2的放大在骨髓瘤中很常见,涉及COPS3.3等基因.
研究的目的:
- 研究COPS3在骨髓瘤干性中的作用.
- 阐明COPS3调节癌症干性的分子机制.
- 确定针对COPS3治疗骨髓瘤治疗的治疗策略.
主要方法:
- 对COPS3表达和茎状特征的相关分析.
- 研究COPS3与SOX2的相互作用及其对降解的影响.
- 评估ITGB2在COPS3核转移中的作用.
- 对SOX2液态液态相隔离 (LLPS) 的观察.
- 在体外和体内对COPS3抑制剂Z-5891.1.的评估.
主要成果:
- 升高的COPS3表达与增加的茎度相关.
- COPS3通过抑制其降解来稳定SOX2,增强转录活性.
- ITGB2促进了COPS3的核转移.
- 在骨髓瘤中,SOX2经历了LLPS,保持了茎状.
- Z-5891有效地抑制骨髓瘤的生长和骨髓瘤骨干.
结论:
- 通过SOX2稳定和LLPS,COPS3是骨髓瘤干的关键驱动因素.
- ITGB2-COPS3-SOX2轴代表了一个新的干度调节途径.
- Z-5891是一种潜在的治疗药物,可以克服骨髓瘤的化学抵抗和转移.
相关概念视频
02:53Adaptive Mechanisms in Cancer Cells
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
02:40Cancer Stem Cells and Tumor Maintenance
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
01:21Lineage Commitment
Commitment is the process whereby stem cells:
02:53Adaptive Mechanisms in Cancer Cells
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
02:40Cancer Stem Cells and Tumor Maintenance
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
01:23Regulation of Expression at Multiple Steps
The gene expression in cells is regulated at different stages: (i) transcription, (ii) RNA processing, (iii) RNA localization, and (iv) translation. Transcriptional regulation is mediated by regulatory proteins such as transcription factors, activators, or repressors—these control gene expression by initiating or inhibiting the transcription of genes. Once a precursor or pre-mRNA is produced, it undergoes post-transcriptional modification, including 5' capping, splicing, and the addition of a...